Similar articles

• Knockdown of zinc finger protein 267 suppresses diffuse large B-cell lymphoma progression, metastasis, and cancer stem cell properties.

  Yang H, Wang L, Zheng Y, Hu G, Ma H, Shen L. Yang H, et al. Bioengineered. 2022 Jan;13(1):1686-1701. doi: 10.1080/21655979.2021.2014644. Bioengineered. 2022. Retraction in: Bioengineered. 2024 Dec;15(1):2299579. doi: 10.1080/21655979.2024.2299579. PMID: 35001816 Free PMC article. Retracted.
• Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma.

  Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA, Fayad L, Medeiros LJ, Vega F. Kim JE, et al. Mod Pathol. 2009 Oct;22(10):1312-20. doi: 10.1038/modpathol.2009.98. Epub 2009 Jul 10. Mod Pathol. 2009. PMID: 19593328
• MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).

  Wang Y, Guo D, Li B, Wang Y, Wang B, Wang Z, Wang M, Teng Q. Wang Y, et al. Leuk Res. 2022 Jan;112:106769. doi: 10.1016/j.leukres.2021.106769. Epub 2021 Nov 29. Leuk Res. 2022. PMID: 34875555
• Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

  Plosker GL, Figgitt DP. Plosker GL, et al. Drugs. 2003;63(8):803-43. doi: 10.2165/00003495-200363080-00005. Drugs. 2003. PMID: 12662126 Review.
• Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.

  Abuelgasim KA, Rehan H, Alsubaie M, Al Atwi N, Al Balwi M, Alshieban S, Almughairi A. Abuelgasim KA, et al. J Med Case Rep. 2018 Mar 11;12(1):64. doi: 10.1186/s13256-018-1612-4. J Med Case Rep. 2018. PMID: 29524963 Free PMC article. Review.